Loading clinical trials...
Loading clinical trials...
A Placebo Controlled Study With a Nasal Spray Containing Glucose Oxidase, Aiming to Induce a Faster Recovery From an Episode of Common Cold
Glucose oxidase is a hydrogen peroxide producing enzyme, which also is present in honey. Human rhinoviruses are sensitive to the action of hydrogen peroxide, which is documented in laboratory studies. In the present study we aim to investigate if a nasal spray with glucose oxidase could treat a common cold, when the treatment is started even after the onset of the symptoms. The study is randomized and placebo controlled.
Persons that are convinced of that they have caught an episode of common cold can be included into the study within 24 hours after the onset of symptoms. Before they start the treatment with the nasal spray they perform a viral sample from the nose and also fill in the WURSS-21 protocol. After this the persons spray with glucose oxidase+glucose/only saline+glucose 5 times the first day and thereafter 3 times daily for a total treatment of one week. Every day the included persons fill in the WURSS-21 protocol.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Öronmottagningen
Södra Sunderbyn, Sweden
Start Date
January 1, 2013
Primary Completion Date
August 1, 2013
Completion Date
September 1, 2013
Last Updated
January 27, 2016
90
ACTUAL participants
Glucose oxidase + glucose
DRUG
Saline+glucose
DRUG
Lead Sponsor
Krister Tano
NCT06531707
NCT06716645
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05944705